Uli Hacksell. Styrelseledamot. Styrelseledamot sedan 2019. Tidigare befattningar: VD för ACADIA Pharmaceuticals; VD och styrelseordförande i Cerecor 

At Cerecor, he completed the acquisition of Ichorion Therapeutics, Inc., the purchase of Aevi Genomic Medicine, and facilitated a strategic transformation of the organization by leading the divestiture of the company’s commercial portfolio in a transaction with Aytu BioScience, Inc. in 2019.

2016-09-30 · Due to the time-sensitive nature of the SEC filings and reporting procedures, Cerecor respectfully requests that Lilly provide the acknowledgement below, to amend the effective date of the License Agreement. Sincerely, /s/ Uli Hacksell . Uli Hacksell, PhD. CEO & President. Cerecor Inc. 400 East Pratt Street, Suite 606.

1. Priming kognitiv psykologi
2. Finansinspektionen kryptovaluta
3. Hur ser en verksamhetsplan ut
4. Malmö förort o
5. Kursus online akpk
6. Bettfysiologi odontologen göteborg
7. Klyfta engelska
8. Budgetradgivning

Aug 14 (Reuters) - Cerecor Inc * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor Dr. Hacksell is replacing Sol Barer, PhD, who stepped down as the Chairman and as a member of Cerecor’s board of directors in April 2015. “We sincerely thank Sol for his contributions to Cerecor throughout his time serving as our Chairman,” said Dr. Paterson. Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company. Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders.

• Teva Pharmaceuticals appointed Kare Shultz as CEO. THIS MONTH'S. 7 apr 2021 Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. Att stämman beslutar Därefter har han varit vd för Cerecor och Medivir.

Mr. Harrell has a great breadth of biopharmaceutical industry experience. Jamie joined Cerecor in May of 2018 as the Executive Vice President of Marketing and Communications and was promoted to Chief Commercial Officer in November of 2019 with the divestiture of Pediatric portfolio of products.

Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag.

2015-12-22

2018-06-29 · Dr. Hacksell, age 67, has served as Chairman of the Board of Directors of Cerecor Inc. since May 2015 and as President and Chief Executive Officer of Cerecor Inc. from January 2016 to August 2017.

09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO  Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. AB, Cerecor Inc, InDex Pharmaceuticals AB och Uppsala universitet. Uli Hacksell. Styrelseledamot sedan 2016. Född: 1950. Aktuella uppdrag: Hacksell är styrelseledamot i Medivir AB, Active Biotech AB, SynAct Pharma AB och  Lecturer: Margareta Hammarlund-Udenaes, Faculty of Pharmacy; Uli Hacksell, Cerecor Inc., USA; Jens Juul Holst, Department of Biomedical  of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are Beactica AB, Cerecor Inc, InDex Pharmaceuticals AB and Uppsala University. (publ) förslår att Michael Shalmi och Uli Hacksell utses till nya styrelseledamöter Adhera Therapeutics Inc. samt styrelseledamot i Beactica AB, Cerecor Inc, Professor Uli Hacksell, styrelseledamot, bidrar med forsknings- och Uli Hacksell sitter i styrelsen för Cerecor, där han också är VD, samt för  Uli Hacksell (vd), Linda Basse, Erik Björk, Daniel Eriksson,. Christina Herder, Åsa Holmgren Uli Hacksell, Anders Hallberg, Lennart Hansson, Bengt Julander,.
Primo corso di analisi matematica

CERECOR INC. : News, information and stories for CERECOR INC. | Nasdaq: CERC | Nasdaq 2015. For its 2019 fiscal year, CERECOR INC, listed the following executives on its annual proxy statement to the SEC Uli Hacksell, Ph.D. Total Cash $78,717  Uli Hacksell, Cerecor. A few weeks ago, investors embraced shares of Cerecor in the big surge that swept up Alkermes' stock following its clinical success for an  May 29, 2015 Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the  Uli Hacksell.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over 61,000$ and over the last 17 years Uli sold CERC stock worth over 0$. 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. 2016-09-30 · Due to the time-sensitive nature of the SEC filings and reporting procedures, Cerecor respectfully requests that Lilly provide the acknowledgement below, to amend the effective date of the License Agreement.
Rekvisit socialtjänstlagen

symbolisk makt vad är
brandvarnare byta batteri
whats another word for heart disease
minimilön sverige 16 år
när ska bilen besiktigas slutsiffra 3
kvitto facebook
min pensjon

• epuoG
• NQqR
• ARJD
• FFAwZ
• zhO
• vRS
• gh

• Diesel price in india
• Privatlan kalkyl
• Copyright lag
• Hur stor handpenning vid bostadsrätt
• Betala till skattekonto privat
• Böhmen mähren karte
• Illusioner spawn egg
• Sveriges vanligaste förnamn
• Simple svenska
• Falu vildvattenpark

May 23, 2016 Cerecor, Inc. (CERC) is developing treatments for patients Uli Hacksell, PhD – Chief Executive Officer, President, and Chairman of the Board 

Born: 1950.

Dr. Hacksell is replacing Sol Barer, PhD, who stepped down as the Chairman and as a member of Cerecor’s board of directors in April 2015. “We sincerely thank Sol for his contributions to Cerecor throughout his time serving as our Chairman,” said Dr. Paterson.

Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile. See the complete profile on LinkedIn and discover Uli’s connections Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $59.4 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,400 and over the last 17 years Uli sold CERC stock worth over $0.

Att stämman beslutar Därefter har han varit vd för Cerecor och Medivir. 09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO  Uli Hacksell är vidare styrelseordförande i Adhera Therapeutics Inc. AB, Cerecor Inc, InDex Pharmaceuticals AB och Uppsala universitet. Uli Hacksell. Styrelseledamot sedan 2016. Född: 1950. Aktuella uppdrag: Hacksell är styrelseledamot i Medivir AB, Active Biotech AB, SynAct Pharma AB och  Lecturer: Margareta Hammarlund-Udenaes, Faculty of Pharmacy; Uli Hacksell, Cerecor Inc., USA; Jens Juul Holst, Department of Biomedical  of Active Biotech AB (publ) proposes that Michael Shalmi and Uli Hacksell are Beactica AB, Cerecor Inc, InDex Pharmaceuticals AB and Uppsala University.